| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > PR > Inside A Company's News Release - Part One |
|
Advice You - Inside A Company's News Release - Part One
Most investors read a company’s news releases, but don’t read between the lines to understand in which direction the company is heading. Too often, a company tries to say everything in the headline and the first paragraph. Why? Because they know, as we do, t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product hat most investors scan the headline, a few sentences and perhaps look at some drill intercepts or key technical data (which few really understand). Then, the investor looks at how the share price reacts to the news, rejoicing or complaining on a stock chat ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in oard. Often, key phrases or sentences are buried inside the release, sometimes near the bottom. These may give you a clue as to what is really happening with the company. We pulled up some recent news releases of several uranium companies we have been follo lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ing to help investors read between the lines. Only a keen, ruthless appraisal of each news release, or a series of their news releases, could give you an accurate interpretation of how well the company is doing. Hopefully, the guidance which follows may help here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe you better understand what is really going with a company’s plans. Northwestern Mineral Ventures (TSX-V: NWT; OTCBB: NWTMF) announced on Thursday the completion of its airborne survey. It also announced multiple potential uranium targets in the country of N d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ger (Africa). Reading an earlier interview we conducted with Dr. John North, a director of this company,he told us, “There appear to be no scarcity of drill targets on the concessions.” So what was the big news? The CEO announced they had “identified several ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc near-surface targets with significant uranium mineralization potential.” That wasn’t the news. Not even close. They already knew that! The company covered 24,000 line kilometers, more than 14,000 miles. Their first pass-through was cherry picking. The real easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ews was buried in the third paragraph, “…a second airborne survey to further delineate areas with strong uranium potential is expected to commence in the summer.” That should pick out the strongest targets for drilling at a later phase of the company’s explo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ation. That line also told us they had very encouraging news. If the second airborne confirms strong uranium potential, raising money to push the project through into drilling and advanced exploration will come more easily. Forsys Metals Corp (TSX: FSY) ann and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ unced on May 28th a new “detailed drilling” program on the company’s Valencia uranium deposit in Namibia (Africa). Closely spaced reverse circulation drilling will help add more “measured” resource to the company’s feasibility study. Increasing the measured ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi esource will make it easier for the company to raise the money to develop a uranium mine or sell its deposit to a major company. Sounds good, but a news article Forsys Metals posted on its website was of greater interest to us. A major hurdle in further dev ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a eloping the low grade uranium deposits in Namibia is water. These projects are in a desert. You need water, lots of it, to mine. On May 26th, The Namibian newspaper ran a very encouraging article – good news not only for the Rossing mine, but also for Forsys dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod Metals and UraMin (which also hopes to start mining uranium in Namibia). What was the news? At a breakfast meeting on water conservation and management hosted by the Namibia Economic Society (NES) on Wednesday, NamWater CEO Vaino Shivute, announced, “The des cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin lination plant is back on the table. We are looking into it again how to restart it, look at the problems of the past and learn from that.” With the water issue on its way to a possible resolution, we expect stronger interest in Namibia. UR-Energy Inc (TSX: tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen URE.TO) issued a series of news releases between June 5th and Thursday, announcing a number of significant developments. First, they confirmed their uranium resources on their two primary properties, Lost Creek and Lost Soldier, in Wyoming, by filing Nationa t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel Instrument 43-101 documents. Both resources were higher than the historical resource estimates. Second, the company confirmed the leachability of uranium on its Lost Soldier property. Why is that important? Without the ability to leach the uranium through ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust n In Situ Recovery project, the company would have been forced to raise the money for a far more expensive open pit operation. In an earlier interview, Chief Executive Bill Boberg told us the permeability would be a “go, no-go” consideration on the project. y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products t appears it is a go. Thursday’s news release confirmed that, but buried in the bottom of the news release was a more telling news item. The company is conducting environmental, hydrologic and engineering studies to “generate baseline data.” During the cour . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e of our research in Wyoming, we discovered a company must provide at least one year of baseline data before it can submit its application for a permit to mine in that state. The other piece of data in the news release showed UR-Energy has been working on th elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip s and expected to submit its application by mid 2007. In other words, the company is quickly moving forward to establish its In Situ Recovery operation. See Part Two for the rest of this article. COPYRIGHT © 2007 by StockInterview, Inc. ALL RIGHTS RESERVED tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Description of a Notary Signing Agent How to Think Like an Entrepreneur 7 Ways a Virtual Assistant Can Make You Money
|